| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 900 | $70 | $60.2K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 150 | $120 | $18.6K |
| 52000 | In this procedure, the provider performs an examination of the interior of the bladder, the urethra, and the ureteric openings by means of a cystourethroscope, a thin flexible or rigid tube with a… | 100 | $190 | $18.2K |
| 99203 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the provider… | 150 | $90 | $13K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 130 | $100 | $12.5K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 80 | $140 | $11K |
| 55700 | Code deleted December 31, 2025. | 30 | $200 | $6.1K |
| 51798 | Providers perform this ultrasound to measure the volume of residual urine in the bladder. | 600 | $10 | $4.8K |
| 76872 | The provider inserts an ultrasound probe into the rectum and performs a transrectal ultrasound to assess disorders of the prostate, rectum, and surrounding tissues. | 40 | $110 | $4K |
| 51720 | This is a common treatment for bladder cancer. It involves instilling an anticarcinogenic agent into the bladder through a catheter. The provider leaves the agent in the bladder for a period of time… | 50 | $70 | $3.2K |